510(k) · Cleared
ClearedPonto 5 SuperPower
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Oticon Medical AB · LXB Hearing Aid, Bone Conduction
Cleared on Dec 16, 2021 as substantially equivalent to K161671 (Oticon Medical AB, 2016) and 1 other predicate after a 20-day review. Its family tree reaches back 11 generations to 1986. 1 later device descends from it.
- Decided
- Dec 16, 2021
- Review
- 20 days
- Class
- Class II
- Product code
- LXB
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 11 generations to K861971 (1986). 24 ancestors in all. 1 later device descends from it, 1 citing it directly.
- Root · 11 generations backK861971 Xomed Audiant Bone Conductor W/Improved AA CoilXomed, Inc. · 1986
- 7 generations between
- 3 generations backK161671 Ponto 3, Ponto 3 Power and Ponto 3 SuperPowerOticon Medical AB · 2016
- 2 generations backK190540 Ponto 4Oticon Medical AB · 2019
- 1 generation backK211640 Ponto 5 MiniOticon Medical AB · 2021
- This deviceK213733 Ponto 5 SuperPowerOticon Medical AB · 2021
- Descendant · cites it directly · 0 of its ownK261142 Ponto 5 Mini; Ponto 5 SuperpowerOticon Medical AB · 2026
Show all 11 generations
- Root · 11 generations backK861971 Xomed Audiant Bone Conductor W/Improved AA CoilXomed, Inc. · 1986
- 10 generations backK955713 Nobelpharma Bone Anchored Hearing AidNobelpharma USA, Inc. · 1996
- 9 generations backK984162 Branemark Bone-Anchored Hearing Aid (Baha) System for Pediatric UseNobelpharma USA, Inc. · 1999
- 8 generations backK992872 Branemark Bone-Anchored Hearing Aid (Baha) Cordelle IIEntific Medical Systems, Inc. · 1999
- 7 generations backK080363 Baha Cordelle IICochlear Bone Anchored Systems AB · 2008
- 6 generations backK090720 Cochlear Baha BP100Cochlear Bone Anchored Systems AB · 2009
- 5 generations backK103594 Ponto Pro PowerOticon Medical AB · 2011
- 4 generations backK132775 Ponto Plus and Ponto Plus PowerOticon Medical AB · 2013
- 3 generations backK161671 Ponto 3, Ponto 3 Power and Ponto 3 SuperPowerOticon Medical AB · 2016
- 2 generations backK190540 Ponto 4Oticon Medical AB · 2019
- 1 generation backK211640 Ponto 5 MiniOticon Medical AB · 2021
- This deviceK213733 Ponto 5 SuperPowerOticon Medical AB · 2021
Most influential descendants
Showing 1 of 1 · See all- K261142Ponto 5 Mini; Ponto 5 SuperpowerOticon Medical AB · 2026 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −11 | K861971 | Xomed Audiant Bone Conductor W/Improved AA Coil | Xomed, Inc. | 1986 | — |
| −10 | K955713 | Nobelpharma Bone Anchored Hearing Aid | Nobelpharma USA, Inc. | 1996 | — |
| −9 | K984162 | Branemark Bone-Anchored Hearing Aid (Baha) System for Pediatric Use | Nobelpharma USA, Inc. | 1999 | — |
| −8 | K992872 | Branemark Bone-Anchored Hearing Aid (Baha) Cordelle II | Entific Medical Systems, Inc. | 1999 | — |
| −7 | K080363 | Baha Cordelle II | Cochlear Bone Anchored Systems AB | 2008 | — |
| −6 | K090720 | Cochlear Baha BP100 | Cochlear Bone Anchored Systems AB | 2009 | — |
| −5 | K103594 | Ponto Pro Power | Oticon Medical AB | 2011 | — |
| −4 | K132775 | Ponto Plus and Ponto Plus Power | Oticon Medical AB | 2013 | — |
| −3 | K161671 | Ponto 3, Ponto 3 Power and Ponto 3 SuperPower | Oticon Medical AB | 2016 | — |
| −2 | K190540 | Ponto 4 | Oticon Medical AB | 2019 | — |
| −1 | K211640 | Ponto 5 Mini | Oticon Medical AB | 2021 | — |
| 0 (this device) | K213733 | Ponto 5 SuperPower | Oticon Medical AB | 2021 | — |
| +1 | K261142 | Ponto 5 Mini; Ponto 5 Superpower | Oticon Medical AB | 2026 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1987 | 1 | 0 |
| 1991 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2004 | 1 | 0 |
| 2008 | 2 | 0 |
| 2009 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LXB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LXB device
- #1 K254296 Ossiclear (Ossiclear System)score 14.7 · 11 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K161671 | Ponto 3, Ponto 3 Power and Ponto 3 SuperPowerSummary page 4…CFR §874.3300, Class II Product Code: LXB, MAH Predicate Devices Device 510(k) no. Manufacturer Ponto 3 SuperPower (Primary) K161671 Oticon Medical AB Ponto 5 Mini K211640 Oticon Medical AB Device Descr… | 2016 |
| * | K211640 | Ponto 5 MiniSummary page 4…ice 510(k) no. Manufacturer Ponto 3 SuperPower (Primary) K161671 Oticon Medical AB Ponto 5 Mini K211640 Oticon Medical AB Device Description and purpose of the 510(k) notice The main purpose of this 510(k)… | 2021 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K261142 | Ponto 5 Mini; Ponto 5 Superpower | 2026 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 35 years and passes through 5 companies; a new generation was cleared every 2.5 years on median.
- None of the 24 ancestors has a recall.
- Of its descendants, K261142 (Oticon Medical AB, 2026) has gone furthest, with 0 descendants of its own.
- 2 other devices also cite its predicate K161671.
How does its category compare?
All LXB devicesLXB Hearing Aid, Bone Conduction: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.
FDA decisions per year · LXB
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LXB
79in 2021
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LXB
1in 2018
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LXB
261in 2025
MAUDE reports naming product code LXB, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 4 |
| 2008 | 2 | — | 0 | 110 |
| 2009 | 2 | — | 0 | 76 |
| 2010 | 2 | — | 0 | 91 |
| 2011 | 5 | 189 | 0 | 123 |
| 2012 | 1 | — | 5 | 346 |
| 2013 | 5 | 103 | 0 | 640 |
| 2014 | 0 | — | 0 | 545 |
| 2015 | 2 | — | 0 | 824 |
| 2016 | 4 | 110 | 0 | 692 |
| 2017 | 1 | — | 0 | 379 |
| 2018 | 1 | — | 1 | 336 |
| 2019 | 1 | — | 0 | 497 |
| 2020 | 0 | — | 0 | 547 |
| 2021 | 4 | 79 | 0 | 490 |
| 2022 | 0 | — | 0 | 387 |
| 2023 | 0 | — | 0 | 348 |
| 2024 | 0 | — | 0 | 232 |
| 2025 | 2 | — | 0 | 261 |
| 2026 | 4 | 164 | 0 | — |
What is it indicated for?
Ponto 5 SuperPower sound processors are intended for the following patients and indications: * Patients with conductive or mixed hearing losses, who can still benefit from amplification of the sound. The pure tone average (PTA) bone conduction (BC) threshold (measured at 0.5, 1, 2 and 3 kHz) of the indicated ear should be better than or equal to 65 dB HL for use with the Ponto 5 SuperPower sound processor. * Bilateral fitting is applicable for most…
Read the full statement (289 words)
Ponto 5 SuperPower sound processors are intended for the following patients and indications:
* Patients with conductive or mixed hearing losses, who can still benefit from amplification of the sound. The pure tone average (PTA) bone conduction (BC) threshold (measured at 0.5, 1, 2 and 3 kHz) of the indicated ear should be better than or equal to 65 dB HL for use with the Ponto 5 SuperPower sound processor.
* Bilateral fitting is applicable for most patients having a symmetrically conductive or mixed hearing loss. The difference between the left and right sides' BC thresholds should be less than 10 dB on average measured at 0.5, 1, 2 and 4 kHz, or less than 15 dB at individual frequencies.
* Patients who have a profound sensorineural hearing loss in one ear and normal hearing in the opposite ear (i.e. single sided deafness or "SSD"). The pure tone average (PTA) air conduction (AC) threshold of the hearing ear should then be better than or equal to 20 dB HL (measured at 0.5, 1, 2 and 3 kHz).
* Also indicated for any patient who is indicated for an air-conduction contralateral routing of signals (AC CROS) hearing aid, but who for some reason cannot or will not use an AC CROS.
The placement of a bone anchored implant is contraindicated for patient below the age of 5.
The Ponto sound processors are intended to be used with either the Ponto implant system or with specific compatible Baha abutments/implants from Cochlear Bone Anchored Solutions (BAS) (refer to the Ponto labeling for specific compatible Cochlear models). In addition, selected Cochlear Baha sound processors can be used with the Ponto implant/abutment system (refer to the Ponto labeling for compatible Baha sound processor models).
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K213733 · printed Nov 6, 2026
Cite this page
510(k) Report. “K213733: Ponto 5 SuperPower.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K213733
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026